{
    "Trade/Device Name(s)": [
        "ADVIA Centaur TnI-Ultra Master Curve Material (MCM)",
        "ADVIA Centaur Digoxin Master Curve Material (MCM)"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K140267",
    "Predicate Device Reference 510(k) Number(s)": [
        "K100594",
        "K102044"
    ],
    "Regulatory Class": "Class I Reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "February 4, 2014",
    "Summary Letter Received Date": "February 7, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "tdm"
    ],
    "Analyte(s)": [
        "Troponin I",
        "Digoxin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVIA Centaur Systems"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Reference Material",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Centaur TnI-Ultra and Digoxin Master Curve Materials used for calibration verification on ADVIA Centaur immunoassays.",
    "Indications for Use Summary": "For in vitro diagnostic use in the verification of calibration and reportable range of the ADVIA Centaur TnI-Ultra and Digoxin assays.",
    "fda_folder": "Clinical Chemistry"
}